In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Start-Up Previews, March 2015

Executive Summary

This Month's Profile Group, Point-Of-Care Testing Stirs Anew, features profiles of GeneWEAVE, HiberGene, Spectromics, and Xagenic. Plus these Start-Ups Across Health Care: 3Scan, Intact Vascular, and Valorem Surgical.

You may also be interested in...



3Scan Inc.

Pathology workflow hasn’t changed much since the field began some 100 years ago – tissue is sectioned with a microtome, mounted to a glass slide, and placed into a microscope – but the process could dramatically change for the better, thanks to the digital Knife Edge Scanning Microscope from 3Scan Inc. What has traditionally been a manual and qualitative process, KESM facilitates with high throughput, quantified image analysis and computation of tissue sliced as thin as 1 micron.

Valorem Surgical LLC

Another player in the rapidly growing minimally invasive approach to lumbar spine fusion has received the green light from the FDA. In January, Valorem Surgical LLC received 510(k) clearance for its MaxiMIS Spinal Fixation System, which provides stabilization and immobilization of spinal segments. MaxiMIS was specifically engineered to minimize tissue disruption, blood loss, and trauma.

HiberGene Diagnostics Ltd.

Dublin-based start-up HiberGene Diagnostics Ltd. aims to create rapid, accurate, and simple diagnostic tests for infectious diseases based on LAMP (loop-mediated isothermal amplification) technology, which uses nucleic acid amplification to identify target genes.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

LL111109

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel